Medical device recalls & advisories across 7 jurisdictions
Alerts are automatically fetched from Health Canada, FDA, EUDAMED, MHRA, TGA, PMDA, and NMPA every hour. Subscribed users receive email notifications for new alerts.
200 alerts across all jurisdictions
Potential device interaction issue associated with the use of the bridge prep kit with the bridge occlusion balloon catheter. Specifically, in some cases, the catheters may experience resistance when being advanced over the 0.035" InQwire® Amplatz Guide Wire supplied in the bridge prep kit.  This impacts unexpired lots of the bridge prep kit.  Note: the bridge occlusion balloon is within specifications and does not present any issues when used with a conforming 0.035" guidewire.
Hydrophilic coated guidewire may swell inconsistently when exposed to saline, causing coating clumping and potential particle detachment. Released particles could enter the bloodstream and potentially cause embolic events. Users should immediately discontinue use of affected devices, quarantine inventory, and follow recall instructions for return.
ICU Medical has identified a lot-specific manufacturing issue affecting certain Portex™ endotracheal tubes that were manufactured with a resin that has variability in the percentage of plasticizer, potentially contributing to a softer material in some units.
ICU Medical has identified a lot-specific manufacturing issue affecting certain Portex™ endotracheal tubes that were manufactured with a resin that has variability in the percentage of plasticizer, potentially contributing to a softer material in some units.
Olympus is providing customers with updated manual reprocessing instructions and trainings regarding the update. The reprocessing instructions were updated to provide greater clarity and specificity for reprocessing of complex device features in alignment with current reprocessing guidelines.
Getinge has identified that some CARDIOSAVE® devices may contain a power management board (PMB) and/or solenoid control board (SCB) with one or more capacitors installed with reversed polarity. These capacitors may degrade over time, potentially causing CARDIOSAVE® device battery charging failures, an inability to power on, interruption of therapy, or unexpected shutdown. The device may continue to function as intended, since the component degradation is not an immediate effect. Continued operation in this condition may eventually lead to a circuit malfunction, affecting critical system functions as outlined in the factors contributing to risk. Functional testing of the PMBs and SCBs may not identify every affected assembly unless capacitor polarity is specifically inspected and verified.
Stryker has identified the following software bugs with Blueprint® versions 4.2.2 and 4.3.1: ---Version 4.3.1 only: PSI guides generated using the incorrect axis when planning with a perform monopost standard  baseplate and a BIO-RSA® Angled graft ---Version 4.2.2 & 4.3.1: Pyrocarbon humeral heads selectable with hrs flex procedures. Pyrocarbon heads are labeled for use with Tornier Flex only.
Teleflex has initiated a voluntary recall for specific lots of the above-listed products because there is a potential quality issue affecting the supplied hydrophilic coated spring wire guide (SWG) components. Teleflex has confirmed the coating may swell inconsistently when hydrated with saline leading to clumping of the coating and potential for detachment.
Teleflex has initiated a voluntary recall for specific lots of the above-listed products because there is a potential quality issue affecting the supplied hydrophilic coated spring wire guide (SWG) components. Teleflex has confirmed the coating may swell inconsistently when hydrated with saline leading to clumping of the coating and potential for detachment.
Certain molded and VFI seats supplied on Raz shower commode chairs were not built to Raz specifications. These seats can break and potentially result in injuries. Stop using the chair with the affected seat. Raz will provide a replacement seat at no cost.
Beckman Coulter has identified an issue that may affect the reporting of clinical chemistry test results. When a laboratory selects a reporting unit other than the system regional default unit for a clinical chemistry test and multiple tests are ordered under the same sample ID, or multiple replicates of the same test under the same sample ID, the software may incorrectly apply the unit conversion factor more than once. This may result in an erroneous reported value.
List of Field Safety Notices from 9 to 13 November 2026.
Boston Scientific is initiating a Product Correction (IFU update) to provide additional guidance in the use of the Clinician Programmer feature for Implantable Pulse Generator (IPG) battery recharge interval and non-rechargeable IPG battery longevity estimates.
Philips has identified two software issues affecting Azurion R3.1 systems that may result in loss of imaging (X-ray) functionality, and/or loss of motorized movement. Issue 1 - System remains in continuous restart mode after the start-up:Due to a software issue, the License Manager - which verifies installed licenses and enables optional functionality in the Azurion system based on the available licenses - expands the Windows registry database at every system start or restart. Over time, the registry may grow beyond the maximum size that the License Manager can load. When this happens, the License Manager cannot start and the system will enter a continuous reboot loop. The Azurion system will not complete booting, and the message "X-ray system is booting..." remains displayed on the screen.Issue 2 - Longitudinal position error - Applicable only to azurion systems with Poly-G3 frontal stand:When requesting a movement of the frontal stand in longitudinal direction, the Azurion system may detect a mismatch between the expected longitudinal (set-) position and the measured (actual) position of the stand. This mismatch is caused by a glitch in the longitudinal position value provided by the position sensing potentiometer.When the mismatch is detected, the motion power to the frontal stand is automatically cut off. The message "Some stand movements are not available" is displayed to the user.In this situation, X-ray imaging and table movements will continue to function.This issue can be resolved with a cold restart of the system or by restarting the geometry.
BVI identified a potential seal integrity issue affecting certain units of the products listed in this Voluntary Medical Device Recall notice. The issue may result in an "open seal" condition, in which sterility cannot be guaranteed. the condition has been confirmed through physical investigation, including visual inspection and dye penetration testing. Based on the investigation and sampling performed to date, the condition is intermittent and does not affect all units within the affected lots.
Hotfix syngo MR XB10B-HF02 (NX2510-WSMW) is a bug fix update (delta installation) which includes:• BioMatrix Head/Neck Pro Coil elements detection fixed for the system configurations with Tim[108x24]and Tim[108x48]• Improved data logging to improve error case detection• Improved general system stability during and after start-up• Improved stability and reliability of the patient table
Cybersecurity vulnerability affecting Centricity Universal Viewer (UV) and Centricity PACS-IW (PACS-IW) when launched from third-party applications via an unencrypted URL method. This vulnerability could allow an unauthorized individual to access the system and potentially view and manipulate patient data. Unauthorized access could also result in exposure of protected health information.
Customer notification for Spectra Optia Systems running software version 12.1 is intended to ensure awareness of the issue and support informed software management decisions. The general patient population being treated with plasma exchange is unlikely to experience issues with the AIM system. The population at greatest risk can experience a delay in treatment if the aim system cannot be disabled.
Hotfix syngo MR XB20A-HF02 (NX2510-WSMW) is a bug fix update (delta installation) which includes:• BioMatrix Head/Neck Pro Coil elements detection fixed for the system configurations with Tim[108x24]and Tim[108x48]• Improved data logging to improve error case detection• Improved general system stability during and after start-up• Improved stability and reliability of the patient table
Star Pharmaceuticals Limited have informed the MHRA of a typographical error on the strength of hydrochlorothiazide printed on the front face of the carton which incorrectly states “12. mg” instead of “12.5 mg”.
Merit Medical Systems, Inc. (Merit) is conducting a voluntary recall of the Workstation Sheath and Dilator due to the radiopaque tip of the sheath detaching. To date, 4 (four) product complaints have been reported; 2 (two) of these product complaints were adverse events.
Carestation 850 and 850c Anesthesia Systems can deliver reduced concentration of anesthetic agent.
Voluntary product removal due to potential particulate contamination resulting from contact between the ball spring and mixing container during manufacturing. The affected products include specific lots of Accell Connexus® (IsoTis OrthoBiologics) distributed in Canada.
List of Field Safety Notices from 02 to 06 October 2026.
In October 2026, the legal manufacturer Sysmex notified Siemens Healthineers of an urgent field safety notice for the analyzer CN series systems.Sysmex identified that deposits may accumulate on the sample arm B probe of the CN-series analyzers.The deposits may affect sample dispensing, potentially resulting in the delivery of a lower sample volume to the reaction cuvette than defined, which and may cause falsely decreased results. Based on the manufacturer’s investigation, the accumulation of deposits occurred due to insufficient washing of the sample arm B probe independent from the assays used.
During manufacturing, insufficient tetrahydrofuran (THF) solvent is used to bond the soft connectors onto the Smoothbore tube. Following reports received from the market of disconnection of the soft connectors from the tube, our investigation and testing of internal stock has identified insufficient amount of solvent used to ensure a secure connection.
The lid lock on some ROTOFIX 32A Centrifuges may not always engage securely. In these instances, the handle bar/lid latch could be open during a centrifuge run.
Siemens Healthineers is advising customers of a software issue affecting syngo.via MR Cardiac Analysis MRFlow Quantification when used with Beat Sensor triggering for retrospectively gated 2D cardiac flowexaminations.The issue affects the MAGNETOM MR scanner model MAGNETOM Flow.Ace when operated with one of thesoftware versions and both licenses specified as follows :. Software Versions Numaris/X VA51A, VA60A, VA61A, VA70A, VB10A, VB20A/NX2510;. Beat Sensor / Pilot Tone Cardiac License (11344791) and. syngo.via MR Cardiac Analysis MR Flow Quantification License (7106227 or 11344838)
Certain lots of StatStrip Ketone Test Strips were found to have an increased rate of quality control (QC) test failures during use. While patient whole-blood testing performance is not affected, the affected lots are being recalled to prevent delays in obtaining ketone test results. Users should immediately identify and discontinue their use, and follow the instructions provided in the recall notification. 
It was identified that certain replacement monitors for Horizon W/WI systems released into production beginning in January 2025 were shipped without the VGA cable required to connect the monitor to the computer. As a result, field service engineers may have installed the systems using VGA cables from unknown origin. This created a nonconformance related to the use of unapproved components and a potential risk of increased electromagnetic interference (EMI) emissions from VGA cables that have not been evaluated or approved by Hologic.
Following the Medical Device Recall for WA00014A, Olympus identified 19 additional models that may experience the same failure. Olympus is reminding customers of the Instructions and Caution related to service life from the HF cable IFU to reduce the likelihood of cable failure.
Following the Medical Device Recall for WA00014A, Olympus identified 19 additional models that may experience the same failure. Olympus is reminding customers of the Instructions and Caution related to service life from the HF cable IFU to reduce the likelihood of cable failure.
Aspire Pharma Ltd is recalling specific batches of Tropicamide 1% Eye Drops, solution in single dose containers 0.5ml x 20, due to them being labelled with the incorrect expiry date. The correct expiry date for these batches…
Sandoz Limited have informed the MHRA of errors in the dosing table in the Summary of Product Characteristics (SmPC) for Co-amoxiclav 250/62.5 mg/5 ml Powder for Oral Suspension.
List of Field Safety Notices from 26 to 30 October 2026.
This recall is being issued due to poor aggregation with collagen tubes from this lot. Internal testing of tubes from this lot with normal donor blood showed 5 of 8 definitively abnormal, 1 equivocal, 2 normal. Because the effect varies from tube to tube, a kit from this lot that passes in-house quality control may still contain affected tubes. A tube from this lot may give a falsely low percent aggregation with collagen, which could suggest abnormal platelet function when function is normal. As stated in the procedure insert, any questionable test result should be repeated and performed in duplicate, and results should be interpreted in light of the patient's clinical history and condition.
Olympus has identified that certain customer-loaned surgical devices intended for human use were incorrectly allocated and deployed for animal use and subsequently used for animal purposes. The devices were then returned to Olympus, where they were reprocessed; however, the same devices were subsequently issued to hospitals for human clinical use.
Due to a serious incident with a KayserBett IDA pediatric care bed, model OLAF sold outside Canada, KayserBettenhas conducted a comprehensive risk assessment and determined that the KayserBett IDA model marketed in Canada presents a comparable injury risk. The risk arises solely from failure to follow the documented safety instructions for locking the hand control after use.
Olympus has identified that certain customer-loaned surgical devices intended for human use were incorrectly allocated and deployed for animal use and subsequently used for animal purposes. The devices were then returned to Olympus, where they were reprocessed; however, the same devices were subsequently issued to hospitals for human clinical use.
CWP 800 - defective circuit breakers.
Accord-UK Ltd is recalling one batch of Lercanidipine Hydrochloride 10mg Tablets due to a packaging mix-up involving the incorrect strength.
Philips has identified a safety issue affecting certain Azurion systems potentially leading to loss of imaging functionality. The power distribution unit is an internal assembly of the Philips Azurion system that contains multiple power supplies. Philips has identified that, in certain Azurion systems, one or more of these power supplies can fail due to energy peaks (surge voltages) during start or restart of the system.When a power supply failure occurs during a start or restart, the power distribution unit does not provide the required direct current power to essential system components. As a result, the system does not successfully complete the (re-)start, imaging functionality is unavailable, and the system remains unavailable for clinical use.
QuidelOrtho has confirmed an issue involving Vitros chemistry products A1c slides. Certain generations (gens) of Vitros A1c slides may generate positively biased results. As of 15-Oct-2026, QuidelOrtho has received 58 complaints relating to this issue with no reports of adverse events.
Boston Scientific is providing this advisory regarding the OptiCross™ family of intravascular ultrasound (IVUs) imaging catheters to communicate an update to the flushing instructions, reinforce device preparation and air-management practices, and inform users of upcoming updates to the Instructions For Use (IFU). This advisory applies only to the products listed in attachment 1 from the customer letter.
During internal validation of new replacement batteries, MCP identified an issue on the RotaFlow console. This issue can cause the device to stop battery charging after the battery operation mode has been utilized. Further investigation identified a software problem as root cause. Because of this, all devices on the market are considered affected by this issue.
Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure.
List of Field Safety Notices from 19 to 23 October 2026.
A software issue has been identified in syngo.via MR Cardiac Analysis MR Flow Quantification affecting the evaluation of retrospectively gated 2D cardiac flow data.  The algorithm does not correctly represent the final phase of the cardiac cycle. The evaluation stops at the last trigger time point (TT point), which marks the beginning of the final cardiac phase, instead of accounting for the complete duration of that phase until the end of the cardiac cycle. The final repetition-time interval (TR) is not included in the calculation (“TR missing”). This results in systematic truncation of the cardiac cycle and incomplete loop closure. Consequently, flow quantification parameters (e.g., Forward volume, Avg.Flow/Min) are systematically underestimated. The impact is relevant for Beat Sensor-triggered flow data, for which the flow peak occurs in the very last acquired cardiac phases.
Agilent identified missing hyphens in the IFU for PD-L1 IHC 22C3 pharmDx (GE006), revision 02 (PD005650). Due to an inadvertent formatting change in section "9.2 tissue sections," tissue-section thickness was incorrectly listed as 45 μm instead of 4-5 μm, and slide-storage temperature was incorrectly listed as 28 °c instead of 2-8 °c. This issue is limited to the electronic IFU (eIFU) associated with the three lots.
The service pack NX VA60A-SP04 is a bug fix update (full installation) that solves/improves the following: Latest it security deliveries and increase in overall stability (syngo MR XA60A-SD12 content included) Installation of multiple SW delta packages now possible at the same time EU DataAact (EY) 2023/2854 implementation:access to all machine data Solved image loading errors for MR Breast Biopsy General MR Protocol Manager improvements Coil specifications adjusted for BM Body 18 Pilot Tone and Spine 32 and 1.5T Sentinelle Breast coils image brightness Supporting IEC 60601-1 compliance, enabling predictable and safe system behavior with regard to table movement
BioMérieux has received complaints of false negative results on BIOFIRE BCID2 Panel kit lot 0727226 / pouch lot 3ZQT26 and investigation identified a product issue. This field safety notice is issued due to unintended movement of pouch chemistry in BIOFIRE BCID2 Panel kit lot 0727226, which based on investigation, can lead to an elevated risk of false negative results. All analytes on the panel may be at risk of false negative results. No other BIOFIRE product lots were determined to be impacted.
Summary of the latest safety advice for medicines and medical device users
The service pack NX VA60A-SP04 is a bug fix update (full installation) that solves/improves the following:  Latest it security deliveries and increase in overall stability (syngo MR XA60A-SD12 content included) Installation of multiple SW delta packages now possible at the same time EU DataAact (EY) 2023/2854 implementation:access to all machine data Solved image loading errors for MR Breast Biopsy General MR Protocol Manager improvements Coil specifications adjusted for BM Body 18 Pilot Tone and Spine 32 and 1.5T Sentinelle Breast coils image brightness Supporting IEC 60601-1 compliance, enabling predictable and safe system behavior with regard to table movement 
The manufacturer of the Instant Aid Pregnancy test and Instant Aid Ovulation Tester has identified that these devices were distributed for sale in Canada without the appropriate device licence authorization. These over-the-counter devices are intended for home use to support the early detection of pregnancy and the prediction of ovulation. To date, no incident reports, consumer performance complaints or adverse events associated with these devices have been reported to the manufacturer. 
Certain terms and statements in the instruction manual caused confusion regarding the nature of the product and its intended use. As a result, changes were made to clarify the instructions, improve consumer understanding and ensure the product's safe and proper use.
The service pack NX VA60A-SP04 is a bug fix update (full installation) that solves/improves the following: Latest it security deliveries and increase in overall stability (syngo MR XA60A-SD12 content included)  Installation of multiple SW delta packages now possible at the same time EU DataAact (EY) 2023/2854 implementation:access to all machine data Solved image loading errors for MR Breast Biopsy General MR Protocol Manager improvements Coil specifications adjusted for BM Body 18 Pilot Tone and Spine 32 and 1.5T Sentinelle Breast coils image brightness Supporting IEC 60601-1 compliance, enabling predictable and safe system behavior with regard to table movement
Unlicensed device for both pregnancy test and ovulation test. 
Beckman Coulter has determined that a modification made by operators to 25 predefined calculated rules, which are included as part of the parameter package, will revert to the default expression following parameter package or software upgrades.
Abbott has identified an important security update for the FreeStyle Libre 3 App. This software update is required to maintain security of the apps.  Following the security update to the FreeStyle Libre 3 App (Android and iOS), the software update implemented to mitigate the sensor impersonation vulnerability introduced an unintended defect that, under certain conditions, can result in prolonged loss of communication between the mobile application and the sensor. Customers are advised to immediately update their app to the latest version 3.6.10 to rectify the issues.
Medtronic is initiating this recall to inform customers of an update to the Instructions For Use (IFU) for the Abre™ Venous Self-Expanding Stent System (herein referred to as Abre). This update provides a validated manual deployment workaround method to help mitigate potential harms in the rare event customers experience a partial stent deployment; the method is included in the notification  letter and the Abre IFU will be updated, pending regulatory approvals, to reflect this standardized approach.These instructions should only be followed in the event a partial stent deployment occurs. Medtronic is taking this action to reduce the severity of potential patient harms. The steps provided in the notification are intended to minimize the risk of serious adverse health consequences in the rare event of partial stent deployment.There are no product retrievals or disposals requested by Medtronic as part of this IFU update.
Xeal Pharma have informed MHRA that all strengths of their Clopidogrel Oral Suspension and Clopidogrel Oral Solution products contain less than the labelled amount of clopidogrel.
Abbott has identified that lots beginning with A24, A25, B25, B26, C26, and D26 may have a reduced ability to mitigate certain forms of analytical interference, including macrotroponin and heterophile antibody-related interference, due to variability associated with the alkaline phosphatase component used during reagent manufacturing.  This issue may result in falsely elevated cardiac troponin I results.  There is no evidence that the issue has caused falsely low results. 
Philips Azurion systems use solid-state drives (SSDs) in various PCs to store the operating system and image data and to support system functionality. Philips has identified that, during certain repair or service actions, SSDs that are not specified in the medical device file may have been installed. These SSDs may have different performance characteristics, which may include reduced reliability over time. When an SSD does not perform as intended, the symptoms depend on the PC in which the SSD is installed and the function being used. this may result in loss of imaging functionality or motorized movement, a blank or black display, and/or the inability to store newly acquired images or access previously acquired images.
FP3D™ is a dual cure resin indicated for the 3D printed fabrication of flexible partial dentures in dental laboratories. Each unit is supplied in a 10:1 resin cartridge containing part a resin and part b resin. FP3D™ resin bottles may have been mis-filled during the manufacturing process and inadvertently shipped without part B resin.
Abbott has identified an important security update for the FreeStyle Libre 3 App. This software update is required to maintain security of the apps.
List of Field Safety Notices from 5 to 9 October 2026.
List of Field Safety Notices: 12 October 2026 to 16 October 2026
List of Field Safety Notices from 27 to 31 January 2025.
Stryker identified the Myriad Paediscope handpiece may not fit through the included adapter to connect the handpiece to the neuroendoscope. There are three complaints reported for this issue.
An issue has been identified with the 5 Amp (5A) diode used in the Induction Heater (IH) Control Module on the ARCHITECT i2000SR IH Kit (optional hardware). The diode may be exposed to current exceeding its specified rating, potentially resulting in component failure. Failure could cause localized electrical arcing, circuit board damage, and smoke generation. Only ARCHITECT i2000SR Processing Modules with an Induction Heater (IH) Control Module are impacted.The IH Control Module housing is classified as a fire enclosure in accordance with International Electrotechnical Commission (IEC) 61010-1 and is designed to contain thermal events. Protective features include flame-retardant circuit board material and a metal fire-rated enclosure, which help prevent propagation beyond the module. In all failures, the observed damage remained contained within the IH Control Module, and no injuries or property damage have been reported.There is potential for operator injury and property damage due to smoke, burn, hot surfaces, etc. caused by the excess current on the diode. There have been no occurrences of fire and smoke leading to property damage and no reported occurrences of operator injury for this issue.
Incorrect liver stiffness measures from MR Touch protocol on certain MR systems
A performance issue was identified with HemosIL AcuStar HIT-lgG(PF4-HL ) for the Lot B38062. This performance issue may result in a negative analytical bias and calibration-related failures. Therefore, the Lot B38062 is being recalled and removed from the market as a precautionary measure. 
Siemens Healthineers has confirmed through the investigation of customer complaints and internal investigation that the potential for Repeatability precision to be greater than 10% coefficient of variation (CV) and Within-Lab precision to be greater than 15% CV. Using a 20 - day ANOVA study, Repeatability ranged from 3.09% to 52.03% CV across the assay range when using multiple lots of reagents on the DXC 700 AU and the Viva-ProE. In the same study, Within-Lab precision ranged from 7.72% to 53.39% CV across the assay range.
An issue has been identified where vacuum tubing of the cell rinse unit of the cobas c 303 analytical unit prematurely deteriorated. Investigations confirmed the issue. In the event of small pinholes or cracks, no impact on analytical performance was identified. However, in case of tubing rupture, the following can occur as a result of the issue: Undetected leakage: Fluid may drip into random reaction cells. Result impact: Increased risk of erroneous patient and QC results.
Cochlear Limited is conducting a recall involving a limited number of specifically identified CI1012 Cochlear Implants. A potential condition has been identified that, if present, could result in one or more open circuits affecting individual electrode pathways within the implant.
An update within the Apple iPad Operating System (OS) may reduce Bluetooth disconnections between the Medtronic CareLink™ SmartSync™ (SmartSync) device manager software and its associated accessories.Bluetooth disconnections occur for a variety of reasons. This Apple iPadOS update addresses specific disconnections due to data corruption between the iPad's Bluetooth controller and the SmartSync base station and/or patient connector.Bluetooth disconnections during a SmartSync patient session may lead to harm due to undesirable or incomplete parameter programming.
Philips has identified a software issue that may cause the Flexvision software application to become unresponsive during clinical use. When this occurs, the FlexVision monitor may either:• turn blank and no longer display live images or other information shown on the FlexVision monitor; or• freeze on the last displayed screen and no longer update live images or other information shown on the flexvision monitor.A cold system restart is required to restore normal FlexVision display functionality.
An update within the Apple iPad Operating System (OS) may reduce Bluetooth disconnections between the Medtronic CareLink™ SmartSync™ (SmartSync) device manager software and its associated accessories.Bluetooth disconnections occur for a variety of reasons. This Apple iPadOS update addresses specific disconnections due to data corruption between the iPad's Bluetooth controller and the SmartSync base station and/or patient connector.Bluetooth disconnections during a SmartSync patient session may lead to harm due to undesirable or incomplete parameter programming.
Tracoe is issuing a Field Safety Notice as the application bears a very low risk that the silicone sleeve may detach from the guiding catheter when removing the insertion system of the tracheostomy tube. The sleeve may remain in the cannula and block it, requiring an immediate cannula change, or it may slip into the trachea, necessitating immediate bronchoscopy removal. The incidence rate is very low.
Continuous renal replacement therapy (CRRT) is used for managing severe acute kidney injury and fluid overload. Published evidence has shown that caspofungin can bind to polyacrylonitrile (PAN)-based membranes used in CRRT w…
Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations.
Nova Biomedical has identified quality issues affecting specified lots of StatStrip ketone test strips. The affected lots have been associated with quality-control (QC) failures and Nova Biomedical has initiated a recall, ad…
Field Safety Notices for October 2026
List of Field Safety Notices: 21 to 25 September 2026
Baxter Corporation is issuing a voluntary correction for certain TruSystem 7000 and TruSystem 7500 surgical tables due to a reported issue with the main lift mechanism. The issue has been associated with unexpected wear of the main lift assembly, also known as the telescopic spindle. 
Cardinal Health Presource® has identified various kits that may contain a component impacted by the welmed, extension tubing sets component. that advisory was issued to inform customers of a product condition identified in certain lots and to provide inspection and use instructions to help ensure affected product is identified prior to patient use.
It was identified while using the Avantage inserter handles and grippers during the implantation of the acetabular shell, that the acetabular shell may not consistently disengage from the gripper when the trigger is unlocked. As a result, the inserter handle and gripper assembly may remain engaged with the implanted shell, preventing clean separation of the instrumentation from the implant after its seating.
Under specific conditions following a deep battery discharge, error 29515 may occur during startup of a FreeO2 HW 2.3 device using software package 1.4.2 and prevent its use. The update to software package 1.4.3 corrects this issue and restores the expected startup behaviour. 
Cardinal Health Presource® has identified various kits that may contain a component impacted by the welmed, extension tubing sets component. that advisory was issued to inform customers of a product condition identified in certain lots and to provide inspection and use instructions to help ensure affected product is identified prior to patient use.
Perma-sharp sutures are manufactured for Hu-Friedy by 2 manufacturers. 1. Surgical Specialties Corporation has cleared for the U.S. market & 2. Camark SA are authorized for the European Union, United Kingdom, Switzerland, & Israel. Products have same commercial item number regardless of manufacturer. Henry Schein Inc. has determined that Perma-sharp sutures manufactured for Hu-Friedy by Camark SA were incorrectly distributed in the United States, Canada, Cayman Islands and Uganda.
Vent tube devices across lot 0231048280 were identified to have been released to customers without undergoing sterilization. the issue is currently understood to originate from manufacturing (load preparation) and represents a fault condition: the product does not meet its specification for sterility (SAL 10-6) or its labeled sterile state.
Specific lots of Medline BariatricRollator (SKU: MDS86800XWS), are being recalled due to the front fork stem bolt/wheel assembly disconnecting from the rollator frame tubing. The immediate consequences could include falls resulting in head trauma, bone fractures, or other critical injuries. Customers will be instructed to destroy affected product.
Natus has become aware of complaints related to certain Embletta MPR devices where the device is unable to correctly format its internal memory. When the internal memory cannot be correctly formatted, previously recorded studies may remain on the device and may be updated with incorrect patient information from a subsequent study.  The issue may also prevent studies from initiating recording successfully or may cause recordings to end prematurely, resulting in incomplete or unavailable diagnostic data and the potential need to repeat a patient study. In some cases, users may be unable to download previously recorded studies from the device. Customers are unable to correct the memory formatting issue through normal device operation, and there is currently no workaround available. These conditions may increase the risk of incorrect patient information being associated with a study, loss of diagnostic data, delays in diagnosis, or the need to repeat patient testing.
Cardinal Health was recently informed of a medical device recall from Becton Dickinson concerning the BD Alaris™ Pump Infusion sets used with BD Alaris™ pump module model 8100 referenced.Tthe recall is being issued due to BD requesting the discontinuation of sets.
A battery reading error may occur when certain Freeo2 HW 1.2 devices are restarted following an upgrade from software version 1.2.X to 1.4.X. The error is immediately detectable, prevents the device from being returned to service and requires installation of a resistor at position R39.
Potential issues with the Lumify Diagnostic Ultrasound System which may prevent or delay scanning functionality: Due to a software issue, the Lumify application may not recognize a previously registered transducer and prompt for re-registration (outside of the defined criteria in the user guide) without warning prior to point of care use. Scanning functionality is prevented until the registration step has been completed; registration requires wi-fi or cellular signal access.Lumify devices used outside the hospital, such as in ambulances, aircraft, or field settings, are at greater risk due to reduced access to wi-fi/cellular. Philips has received reports that these erroneous re-registration events have prevented scanning in pre-hospital environments and delayed care to patients. These pre-hospital events occurred outside of wi-fi or cellular access. Additionally, Philips has identified that the connection between the Lumify transducer USB cable to a customer's tablet/ phone may disconnect or have an unstable connection during use which may disrupt continuous function of the device and result in a delay of care.
Norgine Limited is recalling specific batches of product as a precautionary measure due to some units containing the incorrect amounts of active ingredients.
Abiomed has decided to initiate a voluntary medical device recall (removal) for design changes that were previously implemented through the Abiomed field service process. Abiomed performed a retrospective review of Field Change Notices (FCN) and determined that certain AIC consoles in the field did not receive the updates introduced by FCN 113.Failure to implement the applicable FCN 113 updates may result in the screen freezing during the Purge Cassette Change Wizard and the display of a false controller error.These defects could delay the initiation of support during device set-up and, in high-risk patient populations, may lead to temporary inadequate hemodynamic support or a temporary loss of hemodynamic support. Hospital inventory may continue to be used to ensure continuity of care. Not all units are affected by this issue.
Medline Industries, LP is issuing a correction notice for specific lot numbers of the Medline single sterile C-section drapes w/incise due to customer reports of C-section drapes being difficult to remove from patients, leaving adhesive residue on the patient's skin.
Product may detect low levels of HCG below the stated assay sensitivity which may result in false positive test results in samples from non-pregnant individuals. The package insert is being updated to note that low HCG levels can occur at or after onset of perimenopause. Customers should consider this when interpreting results.
Product may detect low levels of HCG below the stated assay sensitivity which may result in false positive test results in samples from non-pregnant individuals. The package insert is being updated to note that low HCG levels can occur at or after onset of perimenopause. Customers should consider this when interpreting results.
Neuraxpharm UK Limited have informed the MHRA that a review of the approved Patient Information Leaflet (PIL) has identified discrepancies between the current Neuraxpharm product safety information and the corresponding refe…
A complaint from the CareLink network reported a sudden decrease in the Remaining Longevity of a patient's Micra VR CIED from 3 years to 6 months following a remote transmission, which was later found to be incorrect. Analysis revealed a calculation issue in SmartSync and CareLink for Micra VR2 and Micra AV2 devices, occurring under specific conditions. This miscalculation stems from a software error where a function received an integer instead of a real data type, defaulting the average pacing rate to 60 BPM and resulting in inaccurate Remaining Longevity estimates. 
GE Healthcare has become aware of an issue in CareIntellect Perinatal (CIP) that may result in loss of monitoring information and clearance of active patient monitoring alarms. When this issue occurs due to an interruption in system connectivity, monitoring data will be unavailable for up to approximately 20 seconds and currently active visual and audible alarm indicators will no longer be displayed or announced at the CIP user interface. Following resolution of system connectivity, alarm triggers will restart based on the configured thresholds. This issue could delay recognition of a maternal or fetal condition requiring clinical assessment or intervention.
Boston scientific is initiating the removal of specific lots of Direxion and Direxion HI-FLO Microcatheters due to a manufacturing issue that may cause difficulty withdrawing the device from the carrier hoop and difficulty advancing or withdrawing the device through a guide catheter.
Philips has become aware of a potential safety issue impacting the Radiography 7000 M system (Model 712010) where the drive function may fail immediately after an exposure, causing the system to remain stationary. The issue may occur with the Radiography 7000 M system immediately after an exposure, causing the drive function to fail and preventing repositioning of the system. The system may remain stationary instead of driving upon activation of the handlebar. The issue is intermittent and has been observed during routine mobile radiography use. 
Ethicon determined that some ETHILON™ Nylon Suture from the lot subject to this recall (removal) have needles that are distorted/twisted in the primary packaging. Up to 17% of the impacted lot may have the needle defect. 
Specific item(s) and lot(s) of Medline Convenience Kits Containing Cannula Components with Female Luer Lock Connectors are being recalled. Medline has identified that the components do not conform to ISO 80369-7 dimensional requirements. The nonconforming dimensions may result in a loose, unstable, or detached Luer Lock connection and, in certain cases, may contribute to leaking or breaking during use, so customers will be directed to remove and destroy affected components.
A recall correction notice for Medline Sterile Surgical Kits containing Medline C-Section Drape w/Incise is being issued due to reports of the drapes being difficult to remove from patients, leaving adhesive residue on their skin. In these cases, patients may experience temporary redness, irritation, or superficial skin injury during removal. When using these devices, customers should follow the mitigation strategies outlined in the notice.
A recall correction notice for Medline Sterile Surgical Kits containing Medline C-Section Drape w/Incise is being issued due to reports of the drapes being difficult to remove from patients, leaving adhesive residue on their skin. In these cases, patients may experience temporary redness, irritation, or superficial skin injury during removal. When using these devices, customers should follow the mitigation strategies outlined in the notice.
A complaint from the CareLink network reported a sudden decrease in the Remaining Longevity of a patient's Micra VR CIED from 3 years to 6 months following a remote transmission, which was later found to be incorrect. Analysis revealed a calculation issue in SmartSync and CareLink for Micra VR2 and Micra AV2 devices, occurring under specific conditions. This miscalculation stems from a software error where a function received an integer instead of a real data type, defaulting the average pacing rate to 60 BPM and resulting in inaccurate Remaining Longevity estimates. 
List of Field Safety Notices from 21 to 25 September 2026.
Summary of the latest safety advice for medicines and medical device users
BD is initiating this voluntary recall notice to inform customers of worse performance, under certain use cases, for the BD Alaris™ Pump Module model 8100 (pump module) when used with a subset of compatible pump infusion sets (see Appendix A). Pump infusion set design features such as in-line filters, back check valves, and Y-sites were identified to adversely impact infusion performance, particularly at programmable rates under 1 mL/h and at or under 1 mL of volume. Compared to the performance described in the user manual, the flow rate and bolus dose accuracy for a subset of compatible pump infusion sets have decreased, and the time to alarm for upstream and downstream occlusions and associated post-occlusion bolus have increased. In this letter, BD is sharing the latest performance data, reiterating existing warnings and mitigations from user manuals, and requesting customers to acknowledge and disseminate this notice within their institutions.   Update (2026-09-28): BD will issue an updated recall notice as some Alaris™ pump sets with restrictive components and designs (e.g., closed male luer, filters, check valves, y-sites, microbore tubing, etc.) Perform worse than previously disclosed. The deviations most commonly occur at low programmable rates under 1 ml/h and at or under 5 ml of "bolus volume". BD has continued to extensively test BD Alaris™ pump infusion sets to ensure the most accurate set performance data is shared with our customers. This testing found that the previously claimed performance was overestimated, and, in some instances, the infusion performance is significantly worse.
The current Amulet™ IFU contains a contraindication against use "where placement of the device would interfere with any intracardiac or intravascular structures." Abbott is updating this contraindication to specifically identify the pulmonary artery as one of the adjacent structures. In addition, Abbott is updating the IFU to include additional guidance about assessing the distance between the device landing zone and the pulmonary artery. Abbott recently completed additional physician training on this subject. For clarification, this recall is not associated with defectiveness or possible defectiveness. Abbott is informing consignees about changes to the instructions for use (IFU) for the Amplatzer™ Amulet™ Left Atrial Appendage Occluder (referred to as Amulet™) regarding pulmonary artery injury (PAI).
Ethicon determined that PERMA-HAND™ Silk Suture subject to this recall (removal) was incorrectly manufactured with an alcohol-based tubing fluid in the primary packaging. This tubing fluid is an isopropyl alcohol (IPA), diethylaminoethanol (DEAE), and sodium benzoate solution previously used in the manufacture of a different suture product. Up to 80% of the impacted lot may have had the alcohol-based tubing fluid. Tubing fluid is not a material approved for use in the manufacture of PERMA-HAND™ Silk Suture.
Medtronic has received 15 complaints involving the selection of an incompatible component based on the intended system configuration between 01-Jan-2020 through 12-Aug-2026. Use of an incompatible lead or percutaneous extension has resulted in a delay of surgery or the need for surgical replacement of the component. Review of complaint data confirmed that the product is functioning as designed and there are no device or product performance issues.
Stryker has observed that some devices may experience premature battery drain. When this occurs, the devices may: not power on; power on with faint audible and visual indicators; be unable to detach a coil as intended.
Baxter Corporation is issuing an urgent medical device correction for the Likorall™ ceiling-mounted overhead patient lift system due to a potential issue involving motor shaft breakage combined with reduced performance of the single fault safety (SFS) system. In rare cases where a double fault failure occurs simultaneously, with both a motor shaft breakage and reduced SFS system performance, customers have reported instances of the lift strap lowering more quickly than expected during use.
B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.
Cook Medical identified that products supplied in the affected device lots may have been manufactured out of specification. Specifically, the female luer lock adapter component may not have been correctly seated due to misalignment and inadequate torquing during manufacturing.
The model 3930M is a transvenous DF4 lead labelled for use in the RV and left bundle branch area (LBBA). It uses a fixed helix design, so the lead must be rotated as a whole for fixation. It's design transfers torque from the connector and lead body to the distal tip, supporting deep septal placement. To support this function, the lead incorporates interlocking mechanical features between the helix and tip to ring (tr) spacer, along with an adhesive bond applied during manufacturing. The adhesive is dispensed manually in a three-step process. All returned product analysis and some initial pho returns showed inadequate adhesive coverage at the tr spacer to helix interface. Current investigation indicates that operator technique and inspection contribute to the root cause. Insufficient adhesive at the interface between the driveshaft assembly and tr spacer causes a weak bond. Torque applied during the implant procedure may cause the adhesive bond to break. The helix then can separate from the TR spacer, referred to as driveshaft separation, while maintaining the overall lead connection with the cable. If separation occurs and the lead is implanted, the helix and cable assembly are unsupported, and lead fracture may occur over time.
List of Field Safety Notices from 14 to 18 September 2026.
Health Canada is advising Canadians about counterfeit laser hair removal machines and therapy systems sold under the “Soprano” brand. The authentic Soprano devices are manufactured by Alma Lasers Ltd. Information on label of the counterfeit product indicates the device is manufactured by  Beijing Perfectlaser Technology Co., Ltd. These counterfeit devices have been advertised and sold to clinics in Canada. Beijing Perfectlaser Technology Co., Ltd. has provided a falsified medical device licence and falsely represented the products as authorized medical devices. This may mislead purchasers into believing that the device has been authorized for sale and meet regulatory requirements when they do not. The manufacturer of the authentic device confirmed that these devices manufactured by Beijing Perfectlaser Technology Co., Ltd are counterfeit. Counterfeit health products are imitations of authentic products but are not the same and may pose serious health risk due to their unknown safety and effectiveness. The sale of counterfeit health products is illegal in Canada. Health Canada protects public health and safety when companies are found to be selling unauthorized health products in Canada, including by warning Canadians when needed. The Department also works with the Canada Border Services Agency to help prevent the import of any unauthorized health products.
GE Healthcare has become aware of an exposed sharp edge inside the SIGNA™ Artist Evo and SIGNA™ Artist electronics cabinet that could damage power cables, which may potentially cause an electrical fault. If the electrical fault is present and the cabinet door is opened while the system is powered, this could potentially result in an arc flash that could lead to serious injury to service personnel in immediate proximity.
The MHRA has conducted a review into the use of wireless cardiotocography (CTG) systems that use radiofrequency (RF) telemetry channels. Signal crossover, erroneous CTG traces and signal dropouts have been identified as pati…
STERIS identified through customer complaints that a small number of RAPICIDE™ Part A bottles within certain lots may begin to bulge or expand over time. Part A is the active component of chemistry that creates peracetic acid, which may off-gas during the shelf-life of the product. Under routine conditions, the Part A bottle cap includes a vent intended to allow gas to escape (off-gassing) and reduce the potential for gas accumulation. If the vented cap becomes blocked, gas may accumulate and the bottle may swell due to increased internal pressure. In some cases, excess vapor or liquid chemistry may escape from the bottle when the cap is twisted during opening, which could result in user exposure if required personal protective equipment (PPE) is not properly used. Such exposure may result in injury to the user or others in close proximity.STERIS will provide a customer notification letter to all consignees who purchased affected lots. Consignees will be requested to follow the appropriate procedures and PPE needed to address any swollen bottles. The chemistry itself remains safe and effective to use in accordance with its labeling. However, replacement product will be provided for any product that had to be disposed.
When exporting diffusion tensor imaging (DTI) scans from a Philips MR system using the Enhanced MR DICOM format, the exports contain incorrect data (diffusion directions). If the Enhanced MR DICOM export is used in conjunction with third-party software for tractography (e.g. for mapping nerve fiber pathways in the brain), the software will not be able to correctly process the DTI data for reconstruction.
Trinity Biotech is recalling Oxalate Reagent B, Product Code 591-2, Lot 2500711 due to performance variability resulting in negative bias and under-recovery of oxalate values, potentially causing falsely low patient results. Users should discontinue use, quarantine affected inventory, and follow recall instructions.
Martindale Pharmaceuticals has informed the MHRA of an error with the linear barcode of some batches of Clobazam 5mg/5mL and 10mg/5mL Oral Suspension 150mL.
In ICCA releases J.06.01 and J.06.02, calculations triggered by infusion-pump auto-charting may result in incorrect Intake Totals, Output Totals, Net Body Balance, Length of Stay (LOS) Balance, and related fluid-balance values.This issue applies only to customers that have configured and use Auto Charting for Infusion Data for a Clinical Unit, with one or both of the following settings enabled:• Automatic periodic charting of infusion rates and volumes.• Automatic aperiodic charting of infusion rates and bolus volumes when a change occurs.Customers that do not have either Auto Charting for Infusion Data setting configured and in use are not impacted by this issue.
The sphere manufacturer has identified variation in the reflective material used on a limited number of sterile passive sphere lots. The reflective material is the outer coating of the sphere that reflects infrared light from the optical tracking cameras, enabling detection and tracking of instruments during navigation procedures. Medtronic has determined that this variability may affect the ability of the navigation system to detect and track the spheres. Potential impacts may include instrument verification failures, intermittent or lost tracking, red status tracking or navigation accuracy.
Fatal and serious harm continues to occur when patients fall from hoists or slings during transfers and repositioning. A review of recent incidents with a fatal outcome and wider surveillance data shows an average of two dea…
List of Field Safety Notices from 7 September to 11 September 2026.
GE Healthcare has become aware of two potential issues associated with certain Centricity High Acuity (CHA) systems. Safety issue #1, involving the order and recording summary component used in displays and printed reports within CHA applications. Safety issue #2, involving the flexible order summary printout component.
Following a product complaint, and as part of its standard quality process, Stryker confirmed that one lot of T2 Alpha IMN advanced locking is incorrectly labeled. The product contains a 75mm length screw instead of 57.5mm.
Beckman Coulter identified a software issue affecting DxC 500i and DxC 500 AU Analyzers when testing plasma samples. Following user configuration of a chemistry test to nondefault units, subsequent activation of a draft configuration in the system configuration page may revert units to the system default without notifying the user.
List of Field Safety Notices from 31 August to 4 September 2026.
Philips has become aware of a software issue affecting Philips Magnetic Resonance (MR) imaging systems operating with software versions R5 & R11, which may terminate an examination during the image reconstruction process. If the scan parameters are manually adjusted such that reconstruction requirements exceed the available system memory, the system will freeze, preventing image generation and requiring a system re-start.
Air bubbles may develop in the monoblock oil when there is a prolonged period between manufacture and installation, for example due to storage, transportation, or other pre-installation holding time. During a clinical procedure, when the user activates X-ray imaging, if an air bubble becomes trapped in the high-voltage area of the monoblock, there could be an internal electrical discharge (flashover) resulting in X-rays not being generated and consequently no image being displayed on the examination monitor. When this situation occurs, the system displays an error message indicating that the X-ray generator is not available. In some cases, restarting the system (which takes approximately 5 minutes) may restore X-ray generation. Philips' investigation indicates that this issue may occur during the early period of system use following a prolonged period between manufacture and installation. Based on the investigation, potentially affected systems have been identified as those for which more than 300 days elapsed between manufacture and installation and fewer than 250 days have elapsed since installation with continued system use, the monoblock oil temperature increases, allowing storage-related air bubbles to gradually dissipate over time.
During production of LP35, Stryker identified that certain printer and modem access port connectors may not have been fully seated within the rear housing assembly. As a result, the connectors may appear flush with or recessed relative to the retaining nut rather than extending beyond it as intended. 
Boston Scientific is initiating removal of Imager II Angiographic Catheters (“Catheters”) due to a manufacturing issue affecting the catheter tip. This removal affects the devices identified in Attachment 1 of the customer letter. Boston Scientific has determined that these Catheters were manufactured with reduced levels of stabilizing agents in the tips. This may increase the risk of tip degradation and detachment. 
Gore has identified through quality control testing that some VIABAHN® devices were processed using equipment that was functioning outside of the validated range. This could potentially result in an incorrect bonding location of the distal tip onto the delivery catheter.
List of Field Safety Notices from 24 to 28 August 2026.
Blood-to-glycol leakage was identified in the heat exchanger during the procedure. Glycol compartment contamination may result in blood contamination of the heater-cooler due to glycol circulation for thermoregulation. Customer communication is considered necessary to inform users of potential heat exchanger leakage and possible blood contamination of the heater-cooler.
Stryker has identified an issue with the LP35 where the device does not display the message "CHECK RHYTHM / ECG Analysis Inconclusive" as intended when specific conditions are present simultaneously. The issue does not affect the display of "shock advised" or "no shock advised" messages, and therapy delivery remains available. Additionally, this nonconformance is limited to the device on-screen prompts only; rhythm analysis is not impacted by this issue.
As a precautionary measure, Balt Extrusion is voluntarily recalling specific ANRYV connector lots after routine quality control identified non-conforming bacterial endotoxin test results. The recall affects both standalone ANRYV connectors and ANRYV connectors incorporated into selected Balt product kits, despite no reported patient harm to date.
Olympus determined that the affected products may have been manufactured without the designated amount of adhesive to the rear of the device’s ceramic tip, which may result in detachment of the ceramic tip. Customers should immediately discontinue using the BiCOAG Hemostasis Probe products and contact Olympus to return the product.
Administration of parenteral nutrition without a filter has been associated with a number of adverse incidents including an embolism which resulted in a fatal outcome.
Unexpected shutdown of Carestation 850 and 850C anesthesia systems when AC mains power is disconnected or AC mains power is lost.
Abiomed has initiated a voluntary medical device recall (removal) after identification of an increase in complaints related to purge cassette recognition issues due to the failure of the purge flag component of the purge pressure sensor assembly. The cause of the purge flag failures is a combination of dextrose buildup from a purge cassette leak and material embrittlement from usage, aging, or exposure to cleaning chemicals. This issue may occur from usage and is not a manufacturing defect. The purge flag component is present in all manufactured Automated Impella Controller (AIC) in Canada. However, product may continue to be used to ensure continuity of care and a prioritized risk-based strategy for component replacement will be implemented. The purge flag is the component that engages with the purge disc and allows the AIC to recognize the purge disc. These AIC purge flag component failures may result most frequently in user inconvenience due to troubleshooting, attempted purge cassette exchange and AIC exchange. If the failure occurs before initiation of support, exposure may result in a delay to procedure, which is expected to remain clinically manageable in most cases. In the case of an urgent need for mechanical circulatory support or if the failure occurs during active Impella support, exposure may result in a temporary period of inadequate hemodynamic support during controller transition.
Cardinal Health was recently informed of a medical device recall from Stryker concerning the StrykeFlow PS  referenced. the recall is being issued due to an increased amount in reported complaints consistently describing leaking from the handpiece during use.
The UDI label for model p7924a13 incorrectly states the product description as "Pro+ 40 MRS surface with x-ray" instead of the actual configuration, which is "Pro+ 36 MRS surface." Model p7924a13 should be used with 36" width bed frames and not 40" width bed frames. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect product identification or selection, potentially resulting in use with an incompatible bed frame.
Cardinal Health was recently informed of a medical device recall from Stryker concerning the StrykeFlow PS  referenced. the recall is being issued due to an increased amount in reported complaints consistently describing leaking from the handpiece during use.
An MHRA investigation has found increased risks of wear and corrosion associated with multiple cobalt-chrome (Co-Cr) modular neck hip stem components, including a potential increased occurrence of revision surgery due to adv…
The manufacturer became aware of this issue during retrospective review of historical packaging verification documentation. It was identified that there have been failures in sterile barrier integrity verification testing. As these failures were not previously addressed in accordance with packaging verification requirements, the packaging may not consistently maintain sterile barrier integrity. Therefore, this FSCA is limited to all products of the PIK line within shelf-life.
CHS was notified by ICU Medical Canada that they are conducting a recall of certain IV sets as discoloration may be present in the drip chamber of the IV sets. ICU Medical IV Tubing Dets with a drip chamber that are within their expiration date are impacted. The products should continue to be used as intended and per facility protocol. CHS Ltd. uses these IV sets in the medical devices they manufacture.
Beginning April 5, 2026, elevated rates of KPC unexpected positives were observed in reagent final QC testing of the BIOFIRE® FILMARRAY® Pneumonia Panel, BIOFIRE® FILMARRAY® Pneumonia Panel Plus, and BIOFIRE® Joint Infection Panel, including in passing product that met final QC negativity requirements. Internal testing of failing product has reproduced KPC unexpected positive results, suggesting KPC nucleic acid (organism or synthetic) contamination in the pouch at levels that can lead to false positive results. Additional testing has confirmed that an isolated component, the outer primer pellet, is sufficient for producing unexpected positive KPC results.
GE Healthcare has become aware that the CARESCAPE Central Station (CSCS) v3.0.x may not resume patient monitoring for at least 3 minutes following a system restart.
Cynosure Lutronic has identified a adverse trend of complaint reports in North America for spark and loud noise resulting in patient burns during vascular treatment with the DermaV laser system. There is a remote possibility that utilizing higher fluences at 1064 nm wavelength with the current cryogen parameters can result in a spark/loud noise being observed during treatment that could potentially result in patient burn.
Summary of the latest safety advice for medicines and medical device users
The manufacturer has became aware of cases in which obvious cracks in the hose of the VentStar® Resus Neo and VentStar® Resuscitaire were detected by the users prior to use. In no case draeger was informed of any negative effects on the health of the affected patients. However, this cannot be completely ruled out if such crack remains undetected.
The NGPod handheld device and NGPod sensor, used to test pH to aid the placement of nasogastric tubes, is being withdrawn from the UK market. The manufacturer has ceased trading in the UK. Users should quarantine all remaini…
List of Field Safety Notices from 17 to 21 August 2026.
The Aisys™ Carestation™ Anesthesia System, Aisys™ CS² and Aisys™ CS² with Et Control, containing certain electronic gas mixer assemblies, can automatically transition to Alternate O2 Control.
Beckman Coulter received customer complaints of lamina fluid leaks in iQ200 Series and DxU 840m/850m Analyzers. The investigation found that a structurally compromised rinse-line check valve may allow fluid to migrate internally and leak onto the table or floor, potentially resulting into exposure to physical or mechanical or chemical hazards.
This recall is regarding inaccurate StO2 readings from the HEMFSM10 ForeSight™ Oximeter Cable due to mispositioning of the sensor cables.  Edwards has identified that during manufacturing, the laterality identification labels may be missing or inaccurately placed on the device. There is potential that the labels on the green cables may have been switched, with the channel 1 cable labeled as channel 2, and the channel 2 cable labeled as channel 1. This will lead to a mismatch as to the left and right values displayed on the monitor and what the labels indicate on the cables. Should this potential issue occur during use, the values displayed on the monitor will be switched and will represent the opposite region being monitored. Therefore, there is a potential for incorrect diagnosis, leading to potential delay of appropriate treatment. If either of the labels are missing, or the flag label and/or the sensor label do not match the channel label on the housing, contact the Technical Support. If the flag and sensor labels correctly correspond to the channel labels, there is no further action required.
Zentiva UK Pharma Limited are recalling one batch of Fingolimod Zentiva 0.5 mg Capsules (BN 4L01372H) as a precautionary measure due to a potential risk of contamination with metal particles.
Philips received reports that some PIC iX systems were frozen and could not be used. It was determined that failure of the watchdog may cause the system to be in an unknown state and therefore potentially prevent alarms from being generated or logged. Following the initial system error which triggers the watchdog, staff may observe unexpected system behavior while the watchdog attempts recovery. The observed behavior depends on the underlying software issue and may include:-Inability to interact with the PIC iX user interface. If real-time waveforms, numeric data,and alarms remain operational, there is no impact to bedside or central monitoring and alarming.-The user will not recognize the device issue before the hazardous situation occurs if theobserved behavior is: Loss of central alarming, Loss of, or frozen, waveforms/data display-Bedside monitors and telemetry devices could generate a "No Central Mon" INOP
IMRIS is conducting a voluntary recall to address a potential risk associated with the ORT300 Operating Room Tables. As part of this action, corrective measures will be implemented to replace the linear actuator and rotation lock mechanism components on affected tables with an updated design.
The charger of the Theragun G4PRO massage device can overheat while charging the device's removable battery pack, presenting the risk of a potential thermal event. Consumers should stop using the charger immediately and contact Therabody, Inc. to receive a replacement charger or credit code. The Theragun G4PRO itself is not affected by the recall but it cannot be used with other chargers.
GE Healthcare has become aware that, under certain conditions, historical imaging data migrated from a legacy system may become incorrectly associated with a different patient. If this occurs, studies or images may be displayed under the wrong patient record, which could lead to misdiagnosis or a delay in patient care.
There is a possibility that the castor wheels of the Flex stand are not properly attached. The wheels may come loose. As a result, the Flex stand may tip over. Users shall schedule a service appointment as soon as possible so that the castor fastenings can be inspected and corrected. 
Merit Medical Systems, Inc., on behalf of its subsidiary, Biosphere Medical, is voluntarily recalling specific lots of the Merit Embosphere® Microspheres due to a supplier-related defect that may affect the device packaging sterile barrier. Specifically, certain lots provided to Merit may contain a hole in the blister packaging. Merit has chosen to remove the units from the market and request that customers immediately stop using or distributing the affected lots and return the affected product to Merit. According to Merit's evaluation of health hazard(s), use of the affected product may result in exposure to pathogens/pyrogens, which could lead to infection. To date, Merit has not received any complaints or reports of patient harm or injury associated with this issue.
A software issue in StatStrip (Gen 2) Glucose and Beta-Ketone Hospital Meters may retain previous patient information during barcode scanning, potentially assigning results to the wrong patient. Users should verify patient identification before accepting scanned data and follow the correction instructions provided by Nova Biomedical.
Do not use rectal catheters in infants, including for colic, gas-related discomfort or constipation. Stop using these products immediately and dispose of any unused devices.
List of Field Safety Notices from 10 to 14 August 2026.
A communication is being issued to customers to provide information to be included in an upcoming change to the Instructions for Use. The additional information provides added details intended to reduce the risk of potential endoscope adherence and inability to spray powder.
ResMed has issued a Field Safety Notice regarding Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024. A fault in the device can cause unexpected interr…
The 6FR suction catheter could not pass smoothly through the 2.5mm sizes of cuffed tracheal tube. This may lead to reintubations if the airway is unable to be suctioned.To date, there have been two complaints reported from united states customers where one required reintubation. No serious patient harm has occurred.
Stryker has become aware that the devices listed in the Customer Letter were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five (5) years. Industry guidance for storage duration of UHMWPE raw material used in the manufacture of implant bearing/articulating material of prosthetic joints is less than five (5) years. Product manufactured using UHMWPE raw material beyond the recommended storage duration has the potential for elevated levels of oxidation. Oxidation of UHMWPE material can impact material properties, potentially resulting in increased wear. 
GE HealthCare has become aware that during a service event to update Portrait Core Services software at a facility, patients who are monitored on Portrait Mobile devices can be discharged from the Portrait monitoring system. 
ICU Medical received reports of discoloration observed in the drip chambers of certain IV tubing sets. 
Health Canada has seized several unauthorized injectable health products—including counterfeit medical devices—from Dyosa Beauty & Wellness Lounge (45 Wellington St. N.) in Hamilton, Ontario, because they may pose serious health risks. Unauthorized health products were also advertised for sale through the business' social media accounts.Many of the seized unauthorized injectable health products are used for cosmetic purposes. They include injectable drugs and medical devices (such as dermal fillers).Selling unauthorized health products—including counterfeit products—in Canada is illegal. Unauthorized health products have not been approved by Health Canada, which means they have not been assessed for safety, effectiveness and quality and may pose serious health risks. For example, they may lack active ingredients, vary in their concentration or contain ingredients, additives or contaminated ingredients not listed on the label that could interact with other medications and foods.Counterfeit health products are imitations of authentic products, but they are not the same and may pose serious health risks. The manufacturers of the authentic versions of the seized medical devices have confirmed that they are counterfeit.Unauthorized injectable health products carry additional significant risks, including infections, scarring, allergic reactions, and other serious adverse outcomes due to contamination, improper handling, or unsafe administration. Several of the health products seized are not labelled in English and French as required in Canada. As a result, information about ingredients, usage, dosage and side effects may not be available to or understood by consumers.Health Canada will act to protect public health and safety when companies are found to be selling unauthorized health products in Canada, including warning consumers when warranted. The Department also works with the Canada Border Services Agency to help prevent the import of any unauthorized health products.
List of Field Safety Notices from 3 to 7 August 2026.
The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK Medical Device Regulations 2002 (UK MDR 2002) or with the EU Medical Devices Regulat…
Medtronic has identified an increase in complaints involving the Bravo CF capsule delivery device where the capsule fails to attach to the esophagus or detach from the delivery device. Medtronic's preliminary root cause investigation has identified a potential condition impacting the component that controls the deployment of the capsule which can then be exacerbated by a failure to keep the delivery device straight as instructed in the user guide, as a potential cause. Risks associated with this issue include patient aspiration/inhalation, perforation of esophagus, obstruction of the airway, hemorrhage/blood loss/bleeding, laceration of the esophagus, a delay in diagnosis, and foreign bodies remaining in the patient.Lots with an expiration date of December 10, 2027, or later are not in scope of this recall and do not need to be returned.
The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs. This DSI replaces advice in DSI/2023/005.
Beckman Coulter has determined that a software defect in AU480 chemistry analyzers using Microsoft® SQL server 2022 express may cause a DB connection error that renders alarmDB unreadable and prevents instrument startup. The issue is associated with transaction log auto-growth, and may cause delays in reporting patient test results to physicians.
Johnson & Johnson Surgical Vision, Inc. is issuing a voluntary recall notice for HEALON EndoCoat™ PRO to inform customers of reports involving difficulty with insertion of the ultra-thin 25g orange cannula. This notice is intended to communicate the potential risks associated with cannula insertion and provide additional clarification regarding insertion technique to support the safe and effective use of the product. This recall does not require removal or return of the product from the market. When used in accordance with the instructions provided in this notice, the product may continue to be used as intended.
Stryker Endoscopy has received an increase in complaints for 1788 out of box failures due to bent connection pins. The bent pin may also damage the mating connector in the CCU. Stryker has investigated and identified a service repair issue which contributed to the bent pins noted with these devices.
Affected lots of BD Chloraprep™ 1 ml applicator (clear) used in CHS Ltd.'s Med-RX wound care kit may exhibit an open/incomplete seal on packaging of the applicator. If an affected BD product with a compromised sterile barrier is used, the applicator may have been exposed to microbial contamination. Use of a potentially contaminated applicator could result in no patient harm or may lead to localized skin/soft tissue infection. Less commonly, systemic infection or other infectious complications may occur. In rare cases, particularly in critically ill, immunocompromised or otherwise medically vulnerable patients, severe infection could be life-threatening.
Stryker Endoscopy has received an increase in complaints for 1788 out of box failures due to bent connection pins. The bent pin may also damage the mating connector in the CCU. Stryker has investigated and identified a service repair issue which contributed to the bent pins noted with these devices.
Testing has identified a potential reduction in sensitivity to the 2026 Bundibugyo outbreak strain which could result in Orthoebolavirus SPP. 'not detected' results when testing on the FilmArray® NGDS Warrior Panel - ca.
List of Field Safety Notices from 27 to 31 July 2026
In April 2026, Dräger issued a follow-up Field Safety Notice expanding the number of Atlan Anaesthesia workstation devices affected by a manufacturing defect that may result in mechanical ventilation failure.
Some lots were manufactured with out-of- tolerance dimensions, and as a result some users have reported difficulty removing the obturator (stylet) following placement of the BD Intraosseous Vascular Access System Needle Sets. Based on complaint reports, bench testing completed by BD and clinical observations, this may occur when pulling back on the drill during the insertion or when failing to pull straight back with the powered driver or incorrectly rotating or trying to unscrew the obturator. These actions allow the rotation and locking of the obturator-needle hub interface for specific lots of the product with out-of-tolerance dimensions. 
Summary of the latest safety advice for medicines and medical device users
Philips has identified two software-related issues affecting Azurion R2.x.10, R3.0, R3.1 and R4.0 systems that may result in delay of therapy, procedural complications and/or inappropriate treatment.Issue 1: Image quality degradationIssue 2: Loss of geometry movements - Applicable to systems with an AD7X table only
Gentherm Medical has received complaints of overheated circuit boards in 0.53% of distributed devices. Overheating can cause the circuit board to stop operating, which may result in a device that shuts down at startup or during use on a patient.Based on the low probability of harm, and absence of reported harm, associated with this issue, users may continue to use the device. In an abundance of caution, it is recommended to have an alternative means of providing therapy available.